Dr. A. D.G. Cooper

The Company is pleased to welcome, in alphabetical order, William R. Baker, Ph.D., currently Chief Operating Officer for Optimer Pharmaceuticals, Inc. in San Diego, CA; A. Robin D.G. Cooper, Ph.D., retired from Eli Lilly Research Laboratories and now principal of Cooper Consulting, Inc.; R.E.W. Hancock, Ph.D., Professor, Department of Microbiology and Immunology, University of British Columbia, and Director, UBC Center for Microbial Diseases and Host Defense Research; and Arnold L. Smith, MD, Professor and Chair, Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia Missouri.
...
Dr. A. Robin D.G. Cooper retired after a 32-year tenure from Eli Lilly Research Laboratories where he was involved in defining Lily's research focus, establishing strategic goals and patent strategy, and managing the Lily-Oxford University partnership.He is the principal for Cooper Consulting, Inc., and consults for numerous biopharmaceutical companies and other biotechnology groups.Dr. Cooper has authored over 100 publications and patents.He received his Ph.D. from Imperial College/Queen Mary College at University of London 1962 and was awarded the degree of D.S.c. in 1982.

Dr. R.E.W. Hancock is an internationally recognized authority on cationic antimicrobial peptides who has authored over 300 publications in addition to being the recipient of numerous major scientific and research-related awards.He is the named inventor on 9 issued and 12 pending patents.